Literature DB >> 9915373

Analysis of gait abnormalities in Huntington disease.

N C Reynolds1, J B Myklebust, T E Prieto, B M Myklebust.   

Abstract

OBJECTIVE: To evaluate patterns of successful gait strategy in Huntington disease (HD) at various stages of illness to improve fall avoidance and maintenance of independence.
DESIGN: Repeated measurements of gait kinematic parameters and joint performance during gait cycles of six HD patients compared to 30 age-matched controls.
SETTING: A standard gait laboratory.
SUBJECTS: Six HD patients, rank-ordered for disease severity from minimal chorea to generalized dystonia, selected because they were ambulatory despite 3 to 17 years' disease duration. One patient was from a nursing home (walked with assistance) and five were living independently, either alone or with a working spouse who was the caregiver. MAIN OUTCOME MEASURES: Standardized gait evaluations (retroreflective markers on standard bony landmarks) from five video angles, fed into digitizer to computer-generate joint angles and standard gait kinematic parameters.
RESULTS: Wide variability in gait kinematic parameters and joint interaction plots (phase plane and angle-angle plots) was observed between individuals and successive trials of the same limb, tending to increase with disease severity. Joint interaction plots show that random, highly variable distractions from planned trajectories are more apparent distally.
CONCLUSIONS: Chorea in HD does not appreciably affect the center of gravity during ambulation, and the consistency of gait profiles at heel strike shows that the ultimate target is achieved in each step despite random and frequent variability during the gait cycle.

Entities:  

Mesh:

Year:  1999        PMID: 9915373     DOI: 10.1016/s0003-9993(99)90308-8

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  9 in total

1.  Gait and Balance Dysfunction in Adults.

Authors:  Salil Manek; Mark F. Lew
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

2.  Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study.

Authors:  Arnaud Delval; Pierre Krystkowiak; Jean-Louis Blatt; Etienne Labyt; Kathy Dujardin; Alain Destée; Philippe Derambure; Luc Defebvre
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

3.  Coexistence of Gait Disturbances and Chorea in Experimental Huntington's Disease.

Authors:  João Casaca-Carreira; Yasin Temel; Marloes van Zelst; Ali Jahanshahi
Journal:  Behav Neurol       Date:  2015-05-06       Impact factor: 3.342

4.  Gait in Huntington's disease and the stride length-cadence relationship.

Authors:  Mary Danoudis; Robert Iansek
Journal:  BMC Neurol       Date:  2014-10-01       Impact factor: 2.474

5.  Autoregressive modeling to assess stride time pattern stability in individuals with Huntington's disease.

Authors:  Helia Mahzoun Alzakerin; Yannis Halkiadakis; Kristin D Morgan
Journal:  BMC Neurol       Date:  2019-12-09       Impact factor: 2.474

6.  The golden ratio of gait harmony: repetitive proportions of repetitive gait phases.

Authors:  Marco Iosa; Augusto Fusco; Fabio Marchetti; Giovanni Morone; Carlo Caltagirone; Stefano Paolucci; Antonella Peppe
Journal:  Biomed Res Int       Date:  2013-06-04       Impact factor: 3.411

7.  A Longitudinal Motor Characterisation of the HdhQ111 Mouse Model of Huntington's Disease.

Authors:  Emma Yhnell; Stephen B Dunnett; Simon P Brooks
Journal:  J Huntingtons Dis       Date:  2016-05-31

8.  Quantitative Gait Analysis in Patients with Huntington's Disease.

Authors:  Seon Jong Pyo; Hanjun Kim; Il Soo Kim; Young-Min Park; Mi-Jung Kim; Hye Mi Lee; Seong-Beom Koh
Journal:  J Mov Disord       Date:  2017-08-31

9.  Three-Dimensional Trunk and Lower Limbs Characteristics during Gait in Patients with Huntington's Disease.

Authors:  Elzbieta Mirek; Magdalena Filip; Wiesław Chwała; Krzysztof Banaszkiewicz; Monika Rudzinska-Bar; Jadwiga Szymura; Szymon Pasiut; Andrzej Szczudlik
Journal:  Front Neurosci       Date:  2017-10-12       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.